Folate Receptor–Targeted Single-Photon Emission Computed Tomography/Computed Tomography to Detect Activated Macrophages in Atherosclerosis: Can It Distinguish Vulnerable from Stable Atherosclerotic Plaques?
Open Access
- 1 January 2014
- journal article
- Published by SAGE Publications in Molecular Imaging
- Vol. 13 (1)
Abstract
The need for noninvasive imaging to distinguish stable from vulnerable atherosclerotic plaques is evident. Activated macrophages play a role in atherosclerosis and express folate receptor folate receptor β (FR-β). The feasibility of folate targeting to detect atherosclerosis was demonstrated in human and mouse plaques, and it was suggested that molecular imaging of FR-β through folate conjugates might be a specific marker for plaque vulnerability. However, these studies did not allow differentiation between stable and vulnerable atherosclerotic plaques. We investigated the feasibility of a folate-based radiopharmaceutical (111In-EC0800) with high-resolution animal single-photon emission computed tomography/computed tomography (SPECT/CT) to differentiate between stable and vulnerable atherosclerotic plaques in apolipoprotein E 7 mice in which we can induce plaques with the characteristics of stable and vulnerable plaques by placing a flow-modifying cast around the common carotid artery. Both plaques showed 111In-EC0800 uptake, with higher uptake in the vulnerable plaque. However, the vulnerable plaque was larger than the stable plaque. Therefore, we determined tracer uptake per plaque volume and demonstrated higher accumulation of 111In-EC0800 in the stable plaque normalized to plaque volume. Our data show that 111In-EC0800 is not a clear-cut marker for the detection of vulnerable plaques but detects both stable and vulnerable atherosclerotic plaques in a mouse model of atherosclerosis.Keywords
This publication has 16 references indexed in Scilit:
- Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stressAtherosclerosis, 2012
- Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: A forthcoming marker for cardiovascular risk?Autoimmunity Reviews, 2012
- Targeted Folate Receptor β Fluorescence Imaging as a Measure of Inflammation to Estimate Vulnerability Within Human Atherosclerotic Carotid PlaqueJournal of Nuclear Medicine, 2012
- Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisationThrombosis and Haemostasis, 2011
- Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and HumansInternational Journal of Inflammation, 2011
- Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaqueContrast Media & Molecular Imaging, 2010
- Imaging of Atherosclerosis in Apoliprotein E Knockout Mice: Targeting of a Folate-Conjugated Radiopharmaceutical to Activated MacrophagesJournal of Nuclear Medicine, 2010
- Shear stress–induced changes in atherosclerotic plaque composition are modulated by chemokinesJournal of Clinical Investigation, 2007
- Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear StressCirculation, 2006
- Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritisAdvanced Drug Delivery Reviews, 2004